NASDAQ:ORMP

Oramed Pharmaceuticals Stock Insider Trading

etoro logo Buy ORMP
*Your capital is at risk
$2.34
+0.0100 (+0.429%)
At Close: Nov 17, 2025

Oramed Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 6.94M and sold 0 ORMP shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 6.94M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 05, 2025
Buy
Common Stock
A-Award
Mayer Arie
Director
Director 6 975
Value: $15.0K
Jun 05, 2025
Buy
Common Stock
A-Award
Mayer Arie
Director
Director 30 000
Value: $64.5K
Jun 05, 2025
Buy
Common Stock
A-Award
Aghion Daniel
Director
Director 8 371
Value: $18.0K
Jun 05, 2025
Buy
Common Stock
A-Award
Aghion Daniel
Director
Director 30 000
Value: $64.5K
Jun 05, 2025
Buy
Common Stock
A-Award
Reznick Yehuda
Director
Director 8 370
Value: $18.0K
Jun 05, 2025
Buy
Common Stock
A-Award
Reznick Yehuda
Director
Director 30 000
Value: $64.5K
Jun 05, 2025
Buy
Common Stock
A-Award
Sank Leonard
Director
Director 6 510
Value: $14.0K
Jun 05, 2025
Buy
Common Stock
A-Award
Sank Leonard
Director
Director 30 000
Value: $64.5K
Jun 05, 2025
Buy
Common Stock
A-Award
Shapiro Benjamin
Director
Director 4 650
Value: $10K
Jun 05, 2025
Buy
Common Stock
A-Award
Shapiro Benjamin
Director
Director 30 000
Value: $64.5K
Jun 05, 2025
Buy
Common Stock
A-Award
Shapiro Benjamin
Director
Director 30 000
Value: $64.5K
Jun 05, 2025
Buy
Common Stock
A-Award
Shapiro Benjamin
Director
Director 4 650
Value: $10K
Jun 05, 2025
Buy
Common Stock
A-Award
Sank Leonard
Director
Director 30 000
Value: $64.5K
Jun 05, 2025
Buy
Common Stock
A-Award
Sank Leonard
Director
Director 6 510
Value: $14.0K
Jun 05, 2025
Buy
Common Stock
A-Award
Reznick Yehuda
Director
Director 30 000
Value: $64.5K
Jun 05, 2025
Buy
Common Stock
A-Award
Reznick Yehuda
Director
Director 8 370
Value: $18.0K
Jun 05, 2025
Buy
Common Stock
A-Award
Aghion Daniel
Director
Director 30 000
Value: $64.5K
Jun 05, 2025
Buy
Common Stock
A-Award
Aghion Daniel
Director
Director 8 371
Value: $18.0K
Jun 05, 2025
Buy
Common Stock
A-Award
Mayer Arie
Director
Director 30 000
Value: $64.5K
Jun 05, 2025
Buy
Common Stock
A-Award
Mayer Arie
Director
Director 6 975
Value: $15.0K
Feb 11, 2025
Buy
Common Stock
A-Award
Kidron Miriam
Chief Scientific Officer
Officer 66 667
Value: $173.3K
Feb 11, 2025
Buy
Common Stock
A-Award
Kidron Miriam
Chief Scientific Officer
Officer 52 000
Value: $135.2K
Feb 11, 2025
Buy
Common Stock
A-Award
Kidron Miriam
Chief Scientific Officer
Officer 74 000
Value: $192.4K
Feb 11, 2025
Buy
Common Stock
A-Award
Hexter Joshua
COO & Cbo
C-Suite Officer 33 334
Value: $86.7K
Feb 11, 2025
Buy
Common Stock
A-Award
Hexter Joshua
COO & Cbo
C-Suite Officer 48 500
Value: $126.1K

About Insider Power

Insider Power is a proprietary algorithm developed by Stockinvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptid...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE